| 1 | MAGEA1, MAGEA10, MAGEA12, MAGEA2, MAGEA3, MAGEA4
|
| Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients.
|
| Andrade VC, Vettore AL, Felix RS, Almeida MS, Carvalho F, Oliveira JS, Chauffaille ML, Andriolo A, Caballero OL, Zago MA, Colleoni GW.
|
| Cancer Immun 8:2.
2008
|
| 2 | CTAG1B, MAGEA3, MAGEA4
|
| Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
|
| Grah J, Samija M, Juretić A, Sarcević B, Sobat H.
|
| Coll Antropol 32(3):731-6.PMID: 18982744 2008
|
| 3 | MAGEA3
|
| The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.
|
| Liu W, Cheng S, Asa SL, Ezzat S.
|
| Cancer Res 68(19):8104-12.PMID: 18829569 2008
|
| 4 | FGFR2, MAGEA3
|
| Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
|
| Zhu X, Asa SL, Ezzat S.
|
| Clin Cancer Res 14(7):1984-96.PMID: 18381936 2008
|
| 5 | CTAG1, MAGEA1, MAGEA3, MAGEA4, MAGEA6, MAGEC1, MAGEC2, SLCO6A1, SYCP1, TPTE
|
| Cancer-testis (CT) antigen expression in medulloblastoma.
|
| Oba-Shinjo SM, Caballero OL, Jungbluth AA, Rosemberg S, Old LJ, Simpson AJ, Marie SK.
|
| Cancer Immun 8:7.
2008
|
| 6 | MAGEA3
|
| Epigenetic control of MAGE gene expression by the KIT tyrosine kinase.
|
| Yang B, Wu J, Maddodi N, Ma Y, Setaluri V, Longley BJ.
|
| J Invest Dermatol 127(9):2123-8. Epub 2007 May 10. 2007
|
| 7 | MAGEA1, MAGEA12, MAGEA2, MAGEA3, MBD1, MBD2, MECP2
|
| Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
|
| Wischnewski F, Friese O, Pantel K, Schwarzenbach H.
|
| Mol Cancer Res 5(7):749-59. 2007
|
| 8 | MAGEA1, MAGEA3
|
| Epigenetic control of MAGE gene expression by the KIT tyrosine kinase.
|
| Yang B, Wu J, Maddodi N, Ma Y, Setaluri V, Longley BJ.
|
| J Invest Dermatol 127(9):2123-8. Epub 2007 May 10.PMID: 17495964 2007
|
| 9 | MAGEA1, MAGEA3
|
| 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
|
| Qiu G, Fang J, He Y.
|
| Clin Biochem 39(3):259-66. Epub 2006 Mar 6. 2006
|
| 10 | MAGEA1, MAGEA3
|
| Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
|
| Kim KH, Choi JS, Kim IJ, Ku JL, Park JG.
|
| World J Gastroenterol 12(35):5651-7.PMID: 17007017 2006
|
| 11 | MAGEA1, MAGEA12, MAGEA2B, MAGEA3, MAGEA4, MAGEA6
|
| MAGE-A gene expression pattern in primary breast cancer.
|
| Otte M, Zafrakas M, Riethdorf L, Pichlmeier U, Loning T, Janicke F, Pantel K.
|
| Cancer Res 61(18):6682-7. 2001
|
| 12 | MAGEA1, MAGEA3, PRAME
|
| The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
|
| Pellat-Deceunynck C, Mellerin MP, Labarriere N, Jego G, Moreau-Aubry A, Harousseau JL, Jotereau F, Bataille R.
|
| Eur J Immunol 30(3):803-9. 2000
|
| 13 | MAGEA1, MAGEA3
|
| Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma.
|
| Kariyama K, Higashi T, Kobayashi Y, Nouso K, Nakatsukasa H, Yamano T, Ishizaki M, Kaneyoshi T, Toshikuni N, Ohnishi T, Fujiwara K, Nakayama E, Terracciano L, Spagnoli GC, Tsuji T.
|
| Br J Cancer 81(6):1080-7 1999
|
| 14 | MAGEA3
|
| Expression of the MAGE 3 gene product in squamous cell carcinomas of the head and neck.
|
| Lee KD, Chang HK, Jo YK, Kim BS, Lee BH, Lee YW, Lee HK, Huh MH, Min YG, Spagnoli GC, Yu TH.
|
| Anticancer Res 19(6B):5037-42. 1999
|
| 15 | MAGEA1, MAGEA10, MAGEA2, MAGEA3, MAGEA4, MAGEA5, MAGEA6, MAGEA7, MAGEA8, MAGEA9
|
| Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.
|
| Serrano A, Lethé B, Delroisse JM, Lurquin C, De Plaen E, Brasseur F, Rimoldi D, Boon T.
|
| Int J Cancer 83(5):664-9.
1999
|
| 16 | MAGEA1, MAGEA2B, MAGEA3
|
| Expression of MAGE-1, MAGE-2 and MAGE-3 genes in human gastric carcinomas; lack of evidence for cytotoxic effects in cases with simultaneous expression of MAGE-3 and HLA-A2.
|
| Ofuji S, et al.
|
| Anticancer Res 18 : 3639-3644. 1998
|
| 17 | MAGEA1, MAGEA10, MAGEA11, MAGEA12, MAGEA2B, MAGEA3, MAGEA4, MAGEA5, MAGEA6, MAGEA7, MAGEA8, MAGEA9, MAGEA9B, MAGEA@
|
| The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28.
|
| Rogner UC, Wilke K, Steck E, Korn B, Poustka A.
|
| Genomics 29(3):725-31. 1995
|
| 18 | MAGEA@, MAGEA1, MAGEA2B, MAGEA3
|
| Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter : implications for MAGE immunotherapy.
|
| Oaks MK, et al.
|
| Cancer Res 54 : 1627-1629. 1994
|
| 19 | MAGEA1, MAGEA10, MAGEA11, MAGEA12, MAGEA2, MAGEA2B, MAGEA3, MAGEA4, MAGEA5, MAGEA6, MAGEA7, MAGEA8, MAGEA9, MAGEA9B, MAGEA@
|
| Structure, chromosomal localization, and expression of 12 genes of the MAGE family.
|
| De Plaen E, et al.
|
| Immunogenetics 40 : 360-369. 1994
|
| 20 | MAGEA1, MAGEA3, MAGEA12
|
| Cloning and analysis of MAGE-1-related genes.
|
| Ding M, et al.
|
| Biochem Biophys Res Commun 202 : 549-555. 1994
|